Model Parameters
91.0%
Measles threshold requirement: ≥93.3% - 95.0%
2 Months
First routine MMR vaccine dose eligible at 12 months
15.0
Stochastic Community Shield Transmission
Agent-Based Ring Network (N=200)
Vaccinated / Protected
Unimmunized / Susceptible
Infected / Viral Chain
Infant (Center)
Protection Breach: Community MMR coverage (91.0%) is below the critical herd immunity threshold (93.3%). Pathogen penetration reaches the newborn.
Maternal IgG Antibody Decay
Susceptibility Window: Transplacentally acquired maternal IgG has a biological half-life of ~30 days. In vaccinated mothers, titers fall below protective threshold (PRNT 1:120) by month ~2.8 (12 weeks), leaving an unprotected gap until MMR dose 1 at month 12.
Key Epidemiological Constants
- Measles $R_0$: 12–18 (Secondary attack rate >90%)
- Maternal IgG Half-life ($T_{1/2}$): 30 days
- Critical Herd Threshold: $1 - 1/R_0 \approx 93.3\%$
- Routine Infant MMR Window: 12–15 months
Clinical Attribution & Post-Mortem Epidemiological Framework
Distinguishing Primary vs Secondary vs Incidental Pathology
When an infant under 12 months contracts measles, epidemiological investigations and autopsies evaluate whether mortality is driven by primary viral destructive effects, secondary bacterial or opportunistic complications, or incidental infection:
Category 1
Primary Viral Pathogenesis
Direct viral cytopathic destruction. Hallmark findings include Hecht's Giant Cell Pneumonia (syncytial formations, Warthin-Finkeldey cells in lymphoid tissues) and acute measles inclusion-body encephalitis.
Category 2
Secondary Complications
Measles causes profound "immune amnesia" via transient CD4+/CD8+ lymphocyte depletion. Common fatalities arise from secondary severe bacterial pneumonias (e.g. S. aureus, S. pneumoniae) or croup.
Category 3
Incidental / Contributing Detection
Measles RNA confirmed via RT-PCR/nasopharyngeal swab, but pathological cause of death originates from independent congenital anomalies, severe trauma, or unrelated metabolic/anatomic conditions.